Study to Evaluate Efficacy and Safety of DR-102 for the Prevention of Pregnancy
- Study Title
- A Study to Evaluate the Efficacy and Safety of DR-102 for the Prevention of Pregnancy
- Teva Identifier
- DSG-PPS-303
- ClinicalTrials.gov Identifier
- NCT01178125
- Study Status
- Completed
- Trial Condition(s)
- Contraception | Female Contraception
- Interventions
- Drug: DR-102
Study Description
Please refer to ClinicalTrials.gov for a description of the trial
Key Participation Requirements
- Gender
- Female
- Age group
- Adult
- Age Range
- 18 Years to 40 Years
- Trial Duration
- 08/01/2010 - 01/01/2013
- Phase
- Phase 3
